What Telegram channels wrote about Pharmaceuticals in July 2026: 128 posts from 87 channels, collected automatically from public Telegram channels.
Все заболевания - К Вашим услугам самая подробная информация о любой интересующей болезни - от банальной простуды до сложнейших генетических патологий. Позволяет искать лекарства по наименованию и отображает основную информацию из инструкции данного средства: - Фармацевтическое действие - Показания к применению - Дозирование - Побочные действия - Противопоказания.
Версия: 5.5
Моды: Получен Premium.
СКАЧАТЬ
Telegram | Чат | YouTube | TikTok | Игры
🔻 BREAKING: TRUMP JUST SIGNED EXECUTIVE ORDER 2026-1947. MEDBED TECHNOLOGY DECLASSIFIED FOR CIVILIAN USE. THE PHARMACEUTICAL INDUSTRY HAS 90 DAYS.
July 15, 2026. 04:00 AM EST. This was signed in silence. No press conference. No cameras. No media briefing.
Executive Order 2026-1947: "Declassification and Civilian Deployment of Electromagnetic Regeneration Technology."
This is not a rumor. This is not speculation. This is a signed federal document.
THE ORDER STATES:
▪️ All frequency-based healing technology currently classified under Department of Defense medical programs is hereby declassified for civilian research and deployment.
▪️ The FDA is prohibited from blocking, delaying, or interfering with the distribution of electromagnetic regeneration devices to the American public.
▪️ Pharmaceutical companies have 90 days to disclose all suppressed clinical trials involving frequency-based treatments — or face criminal prosecution under 18 U.S.C. § 1001.
▪️ Military medical facilities currently operating regeneration technology will begin civilian intake within 120 days.
THE PANIC:
Pfizer stock dropped 14% in pre-market trading. Johnson & Johnson emergency board meeting called at 5:00 AM. Moderna CEO sold $47 million in personal shares before market open.
They KNEW this was coming. They tried to sell before the collapse.
WHY NOW:
Trump's medical advisors presented him with a 3,400-page classified report documenting 61 years of suppressed frequency healing research. The report contained:
— 847 successful clinical trials hidden from the public — 12,000+ patients fully cured of terminal conditions using electromagnetic frequency — Cost analysis showing MedBed treatment at $0.003 per session vs. $150,000 average cancer treatment
Trump read the cost analysis. Then he signed the order.
THE TIMELINE:
▪️ Day 1-30: Full declassification of all research documents ▪️ Day 31-60: FDA forced to approve frequency-based devices ▪️ Day 61-90: Pharmaceutical disclosure deadline (criminal penalties) ▪️ Day 91-120: First civilian MedBed centers open in 12 states
THE DEEP STATE RESPONSE:
They are already trying to kill this. Three major media outlets received calls from pharmaceutical lobbyists at 5:30 AM demanding they do NOT report on EO 2026-1947.
CNN has been silent. NBC has been silent. ABC has been silent.
Their silence IS the confirmation.
If this order was fake, they would be laughing at it on every channel. Instead — total blackout. Total silence. Total panic.
THE TRUTH:
The pharmaceutical industry just received its death sentence. 90 days. That's all they have left. After that, the technology that cures cancer in 42 minutes will be available to every American citizen.
They had 61 years of profit. 61 years of human suffering. 61 years of suppression.
It ends now.
CODE: EO-2026-1947 / MEDBED-DECLASSIFIED / PHARMA-DEATH-SENTENCE
Share this before they find a way to bury it. The blackout is already happening.
https://t.me/MedBedsTechnologyNews
☢️ Ядерная аптека в ИЯМ: фармацевтика на стыке физики и онкологии
В Институте ядерной медицины работает первая в московском регионе ядерная аптека полного цикла. Радиофармпрепараты для диагностики и терапии производятся на одной площадке - от синтеза радионуклидов до контроля качества и упаковки. Это высокотехнологичное производство, работающее по международным стандартам GMP.
Ключевая проблема, которую решает это производство, - короткий период полураспада изотопов. Некоторые активны всего несколько часов. Производство на месте - не логистическое удобство, а принципиальное условие: препарат должен быть свежим, чтобы работать с максимальной эффективностью.
Центральный элемент комплекса - циклотрон, ускоритель, производящий изотопы. На его основе выпускаются препараты для выявления и лечения рака предстательной железы, нейроэндокринных опухолей, лимфом. В том числе - тераностические пары, где одно соединение используется и для визуализации, и для терапии.
Производство сертифицировано по международным стандартам, каждый этап контролируется. Для пациента это означает доступность: технологии, которые раньше были сосредоточены в единичных центрах, теперь доступны в Химках. Диагностика становится быстрее, лечение начинается раньше.
Если вам или вашим близким показана радионуклидная терапия, не откладывайте.
📞 +74951610931 🗣 Узнать больше
#ядернаяаптека #радиофармпрепараты
Имеются противопоказания. Необходима консультация специалиста.
💊ПРИГЛАШАЕМ ФАРМАЦЕВТОВ В ВЕЧЕРНЮЮ СМЕНУ!
✅Требования: - Образование обязательно: средне-специальное / высшее фармацевтическое; - Знание русского языка (узбекский приветствуется); - Знание лекарственных средств, БАДов, витаминов, косметики; - Грамотная консультация клиентов; - Знание работы с кассовыми аппаратами.
✅Условия: - График работы: 1/1 - 2-я смена с 16:00 до 23:00; - Испытательный срок; - Официальное трудоустройство; - Зарплата обсуждается при личном собеседовании.
📍Адрес: г. Ташкент, Мирзо Улугбекский район, ТТЗ-2.
📞Контакт: +998946253100 — Ирина Александровна
🔻 THE BIGGEST HEALTH CRISIS IN AMERICAN HISTORY WAS PURCHASED FOR $6,500.
Look around you. Obesity. Heart disease. Diabetes. They told you it was your fault. They told you it was the fat on your plate.
They lied. And in 2016, researchers found the receipts.
⟁
In the 1960s, the Sugar Research Foundation — the sugar industry's lobby — secretly paid three Harvard scientists the equivalent of $50,000 today.
The assignment was simple: shift the blame for heart disease away from sugar, and pin it all on saturated fat.
Harvard delivered. The review was published in the New England Journal of Medicine in 1967 — the most respected medical journal on Earth. The funding was never disclosed.
⟁
That one purchased study changed what America eats.
It birthed the "low-fat" era. They stripped the fat out of your food — and pumped it full of sugar and high-fructose corn syrup so it wouldn't taste like cardboard.
And here's the part they really don't want you to know: one of those paid Harvard scientists, D. Mark Hegsted, later helped write the official U.S. dietary guidelines. The man on the sugar lobby's payroll designed the food pyramid your family was raised on.
⟁
The result? Since the low-fat guidelines took over, obesity rates tripled. Diabetes exploded. Heart disease never went away.
Your grandparents ate butter, eggs, and whole milk — and stayed lean their whole lives. You were handed "heart healthy" cereal boxes engineered in a boardroom.
⟁
The proof was published in JAMA Internal Medicine in September 2016. The internal documents exist. The names are known. Nobody was ever punished.
They bought the science. The government enforced the diet. And the pharmaceutical industry sells you the insulin.
⬛ X WORLD SIGNAL: PROJECT-226 / HARVARD-PAID-1967 / HEGSTED-FOOD-PYRAMID / RECEIPTS-FOUND-2016
♟ You aren't sick because of bad luck. You're sick because your food pyramid was drafted by a cartel. Eat what your great-grandparents ate.
Share this. https://t.me/XWorld
🏭 فرصه عمل لخريجي #صيدله في مجال #Production
مطلوب #Production_Pharmacist في شركه #Hikma_Pharmaceuticals
🔸 بكالوريوس صيدله. 🔸 خبره من سنه إلى 2 سنوات في مجال الإنتاج الدوائي.
https://vacanciesblog.com/production-pharmacist-at-hikma-pharmaceuticals-company/
🔬 فرصه عمل لحديثي التخرج من كليه #صيدله في مجال #Research_And_Development 🌸
مطلوب #Associate_Scientist_Formulation_Development / #Research_And_Development_Pharmacist في شركه #Hikma_Pharmaceuticals
🔸 بكالوريوس صيدله بتقدير جيد جدًا أو ممتاز. 🔸 حديثي التخرج أو خبره حتى سنتين.
https://www.recruitmentblogs.com/2023/10/rd-vacancy-at-hikma-pharmaceuticals.html
AI drug discovery has attracted billions in investment over the last decade.
The thesis was straightforward: if AI can find better drug candidates faster, the economics of pharmaceutical R&D change permanently. That thesis has proven correct. AI-led discovery pipelines are now generating more candidates than the industry can develop.
That last part is worth paying attention to.
Having a candidate is not the same as having a drug. Every candidate still needs to clear preclinical studies, clinical trials, regulatory review, and real-world deployment. That process takes 12 to 15 years and costs between $1 billion and $2.6 billion per drug, regardless of how the candidate was found.
Discovery and validation move at very different speeds. AI has accelerated one. The other has not changed much.
Validation has always been the more expensive, more time-consuming part of drug development. And the coordination infrastructure that determines whether any of those candidates ever reach a patient, including the data rails, compliance frameworks, and clinical networks, has seen far less investment than the discovery side.
The validation gap is real. Whether it is a science problem, an infrastructure problem, or something in between is a question the industry is only beginning to ask seriously.
